SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-16-000149
Filing Date
2016-04-29
Accepted
2016-04-29 16:04:04
Documents
4
Period of Report
2016-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kannualmeeting.htm 8-K 52351
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 140525
3 EXHIBIT 99.1 exhibit991.htm EX-99.1 8368
4 exhibit991image1.gif GRAPHIC 11822
  Complete submission text file 0000891293-16-000149.txt   219094
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 161606464
SIC: 2834 Pharmaceutical Preparations